These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 62251)

  • 1. Dopamine and schizophrenia.
    Crow TJ; Deakin JF; Johnstone EC; Longden A
    Lancet; 1976 Nov; 2(7993):1027. PubMed ID: 62251
    [No Abstract]   [Full Text] [Related]  

  • 2. Examining the dopamine hypotheses of schizophrenia and of mania using the prolactin response to antipsychotic drugs.
    Silverstone T; Cookson J
    Neuropharmacology; 1983 Apr; 22(4):539-41. PubMed ID: 6134252
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical assessment of dopamine receptor blockade.
    Sedvall G; Bjerkenstedt L; Lindström L; Wode-Helgodt B
    Life Sci; 1978 Aug; 23(5):425-9. PubMed ID: 29184
    [No Abstract]   [Full Text] [Related]  

  • 4. Dopamine receptors, antipsychotic action and schizophrenia.
    Reynolds GP
    J Psychopharmacol; 1999; 13(2):202-3. PubMed ID: 10475731
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug treatment of schizophrenia.
    Silverstone T
    N Z Med J; 1994 Apr; 107(976):145-6. PubMed ID: 7909363
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurochemical alterations in schizophrenia affecting the putative receptor targets of atypical antipsychotics. Focus on dopamine (D1, D3, D4) and 5-HT2a receptors.
    Harrison PJ
    Br J Psychiatry Suppl; 1999; (38):12-22. PubMed ID: 10884896
    [No Abstract]   [Full Text] [Related]  

  • 7. Practical issues in clinical research of schizophrenia.
    Brunello N; Judd LL; Langer SZ; Mendlewicz J; Racagni G
    Neuropsychobiology; 1997; 35(2):57-60. PubMed ID: 9097292
    [No Abstract]   [Full Text] [Related]  

  • 8. [How do clozapine and co. work? Pharmacologic mechanisms of atypical neuroleptics].
    Müller WE
    Pharm Unserer Zeit; 2002; 31(6):537-45. PubMed ID: 12481511
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopamine and schizophrenia.
    Crow TJ; Johnstone EC; Longden A; Owen F
    Adv Biochem Psychopharmacol; 1978; 19():301-9. PubMed ID: 29450
    [No Abstract]   [Full Text] [Related]  

  • 10. [Possible participation of limbic structures of the forebrain in the mechanism of the antipsychotic effect of neuroleptic preparations in schizophrenia (review)].
    Aksent'ev SB; Mokhovikov AN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(8):1254-60. PubMed ID: 6137921
    [No Abstract]   [Full Text] [Related]  

  • 11. Seroquel: a putative atypical antipsychotic drug with serotonin- and dopamine-receptor antagonist properties. Preclinical and early clinical trials in schizophrenia.
    J Clin Psychiatry; 1995 Sep; 56(9):438-45. PubMed ID: 7665549
    [No Abstract]   [Full Text] [Related]  

  • 12. Understanding and treating psychoses: advances in research and therapy.
    J Clin Psychiatry; 1993 Nov; 54(11):445-52. PubMed ID: 7903666
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dopamine D4-receptor variants, schizophrenia and clozapine therapy].
    Ewald HL; Mors NP; Rosenberg R
    Ugeskr Laeger; 1996 Jun; 158(25):3601-3. PubMed ID: 8693618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical and clinical properties of the atypical antipsychotic drug remoxipride.
    Lewander T
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():269A-270A. PubMed ID: 1354034
    [No Abstract]   [Full Text] [Related]  

  • 15. [New anti-psychotic drugs].
    Lôo H; Brochier T; Meidinger A
    Presse Med; 1991 May; 20(19):889-90. PubMed ID: 1676163
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current concepts of the effects of neuroleptics].
    Kostowski W; Płaźnik A
    Psychiatr Pol; 1990; 24(5):28-37. PubMed ID: 1983397
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetics of novel therapeutic targets in schizophrenia.
    Kerwin R; Owen M
    Br J Psychiatry Suppl; 1999; (38):1-4. PubMed ID: 10884894
    [No Abstract]   [Full Text] [Related]  

  • 18. In vivo neuropharmacology of schizophrenia.
    Bigliani V; Pilowsky LS
    Br J Psychiatry Suppl; 1999; (38):23-33. PubMed ID: 10884897
    [No Abstract]   [Full Text] [Related]  

  • 19. Dopamine and schizophrenia--proof at last?
    Harrison PJ
    Lancet; 2000 Sep; 356(9234):958-9. PubMed ID: 11041394
    [No Abstract]   [Full Text] [Related]  

  • 20. Now we understand antipsychotics?
    Lancet; 1990 Nov; 336(8725):1222-3. PubMed ID: 1978074
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.